(株)ミズホメディーの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証STD | 医薬品 | 4595/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2025/05/16 | 日証協 | 385,019株 | -9.84% | 79,081株 | +2795.68% | 680,146株 | -1.42% | 116,850株 | +2.08% |
2025/05/09 | 日証協 | 427,019株 | -15.02% | 2,731株 | -95.32% | 689,935株 | +0.58% | 114,466株 | +49.95% |
2025/05/02 | 日証協 | 502,519株 | -5.47% | 58,329株 | +1064.02% | 685,935株 | -1.24% | 76,335株 | -1.87% |
2025/04/25 | 日証協 | 531,619株 | -6.7% | 5,011株 | -99.15% | 694,559株 | +0.85% | 77,790株 | +4.27% |
2025/04/18 | 日証協 | 569,819株 | +96.95% | 587,829株 | +945.7% | 688,674株 | +1.76% | 74,601株 | -62.91% |
2025/04/11 | 日証協 | 289,319株 | +7.68% | 56,214株 | -25.2% | 676,771株 | -0.5% | 201,147株 | +2.54% |
2025/04/04 | 日証協 | 268,682株 | -1.37% | 75,149株 | +53.59% | 680,179株 | +2.63% | 196,168株 | +96.49% |
2025/03/28 | 日証協 | 272,419株 | +80.15% | 48,929株 | +689.18% | 662,761株 | +0.08% | 99,837株 | +83% |
2025/03/21 | 日証協 | 151,219株 | -28.1% | 6,200株 | -90.19% | 662,206株 | -4.32% | 54,556株 | -18.3% |
2025/03/14 | 日証協 | 210,333株 | -3.3% | 63,222株 | +178.34% | 692,094株 | -2.47% | 66,772株 | +5.93% |
2025/03/07 | 日証協 | 217,519株 | -8.3% | 22,714株 | +72.35% | 709,606株 | -0.45% | 63,034株 | -34.39% |
2025/02/28 | 日証協 | 237,219株 | +10.38% | 13,179株 | -30.56% | 712,801株 | -2.72% | 96,080株 | +36.08% |
2025/02/21 | 日証協 | 214,919株 | -24.14% | 18,979株 | -65.74% | 732,743株 | -4.16% | 70,606株 | -33.08% |
2025/02/14 | 日証協 | 283,318株 | -4% | 55,394株 | -34.53% | 764,527株 | -2.01% | 105,512株 | -47.47% |
2025/02/07 | 日証協 | 295,133株 | -30.18% | 84,606株 | -67.61% | 780,181株 | -9.81% | 200,868株 | -20.73% |
2025/01/31 | 日証協 | 422,719株 | +0.48% | 261,185株 | -17.75% | 865,028株 | +4.63% | 253,400株 | -20.16% |
2025/01/24 | 日証協 | 420,699株 | +51.58% | 317,563株 | +589.14% | 826,777株 | +9.18% | 317,404株 | +28.32% |
2025/01/17 | 日証協 | 277,551株 | -10.28% | 46,081株 | -46.49% | 757,265株 | -5.98% | 247,361株 | -12.98% |
2025/01/10 | 日証協 | 309,345株 | -20.69% | 86,111株 | +355.61% | 805,452株 | +116.8% | 284,273株 | +147.65% |
※株式分割は考慮していませんのでご注意ください。
Page Top